title: The Effectiveness and Safety of Transurethral (Bipolar) Plasmakinetic Resection of Prostate Combined with Thulium Laser for Large Benign Prostatic Hyperplasia (>80ml).
abstract: To evaluate the clinical curative effect and safety of transurethral (bipolar) plasmakinetic resection of theprostate (PKRP) combined with thulium laser in the treatment of large prostates (> 80mL).
  
  
  
  From January 2014 to December 2015, 61 patients with benign prostate hyperplasia(BPH) were treated with PKRP combined with thulium laser (n = 25) or PKRP only (n = 36). We retrospectivelyanalyzed the perioperative status of patients status during 3-month follow-up.
  
  
  
  There was no significant difference between the two groups before treatment (P > .05). PKRP combinedwith thulium laser was significantly superior to PKRP in terms of surgical duration, intraoperative blood loss,postoperative bladder washing time, postoperative complications and time of hospital stay (P < .05). There were nosignificant improvements at international prostatic symptom score (IPSS), quality of life (QOL), maximum flowrate (Qmax), and post-void residual (PVR) urine between two groups after 3 months (P > .05).
  
  
  
  PKRP combined with thulium laser is superior than PKRP only for better surgical duration, lessbleeding, higher efficiency and much quicker recovery. It may be a better choice for the treatment of BPH withlarge prostate (> 80mL).
authors.affiliation: Department of Urology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai 200072, People's Republic of China.
authors.forename: Tiancheng
authors.initials: T
authors.lastname: Xie
authors.affiliation: Department of Urology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai 200072, People's Republic of China.
authors.forename: Peng
authors.initials: P
authors.lastname: Lai
authors.affiliation: Department of Urology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai 200072, People's Republic of China.
authors.forename: Ming
authors.initials: M
authors.lastname: Luo
authors.affiliation: Department of Urology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai 200072, People's Republic of China.
authors.forename: Yunfei
authors.initials: Y
authors.lastname: Xu
mesh_terms: D000368:Aged; D003131:Combined Modality Therapy; D004598:Electrosurgery / Q000009:adverse effects; D005500:Follow-Up Studies; D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects; D008297:Male; D011470:Prostatic Hyperplasia / Q000473:pathology* / Q000601:surgery*; D012189:Retrospective Studies; D013932:Thulium; D020728:Transurethral Resection of Prostate / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D013932:Thulium